Oritavancin diphosphate
Oritavancin diphosphate (LY333328 diphosphate) is a semisynthetic glycopeptide antibiotic developed to combat serious Gram-positive infections. It demonstrates potent bactericidal activity in vitro and has shown efficacy in animal models of skin and bloodstream infections, supporting its research for therapeutic applications.
Product Specifications
Product Name Alternative
Streptococcus pneumonia, cell wall synthesis inhibition, Antibiotic, Bacterial, inhibit, Inhibitor, LY333328, LY-333328, LY333328 Diphosphate, LY333328 diphosphate, LY-333328 Diphosphate, LY 333328, LY 333328 Diphosphate, Oritavancin, Oritavancin diphosphate, Oritavancin Diphosphate, gram-positive organisms
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.85% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (1.01 mM) ; DMSO:137.5 mg/mL (69.13 mM)
Molecular Weight
1989.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15345346 1 Vial
Lentiviral human PTPRD shRNA (UAS) - Lentiviral human PTPRD shRNA (UAS) plasmid
Sign In for Pricing
View Details 
MBS1277536-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
C11orf65 cDNA Clone
Sign In for Pricing
View Details